Skip to main
HNGE
HNGE logo

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. has demonstrated a strong revenue growth trajectory, with an estimated 25% of annual growth in 2024 driven by improving yields, which are anticipated to continue increasing. The company’s current penetration rate of approximately 3.5% among eligible clients is significantly lower than the 9% penetration rate typical of traditional physical therapy, suggesting substantial room for growth. Furthermore, a history of elevated Net Revenue Retention (NRR) rates of 116-117% over the past two years, combined with a favorable outlook on new client acquisitions and programming enhancements, positions Hinge Health for continued revenue growth beyond consensus expectations.

Bears say

Hinge Health's financial outlook appears concerning due to its projected decline in EBIT margins, as management has guided to mid-teens EBIT margins for the second half of 2025, following a 19% margin in the second quarter of 2025. Consensus estimates for fiscal years 2026 and 2027 indicate EBIT margins of only 14.6% and 16.2%, respectively, which signal a weakening profitability trajectory. Such low margin forecasts may raise doubts regarding the company's ability to sustain competitive advantages and deliver strong financial performance in the future.

HNGE has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 14 analysts, HNGE has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $57.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $57.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.